To stay up to date with all the latest IMB news, you can subscribe to the news RSS feed here.
Three new Group Leaders join IMB
The Institute of Molecular Biology (IMB) in Mainz has marked the start of 2012 with the groups of Drs Jean-Yves Roignant, Natalia Soshnikova and Vijay Tiwari beginning their research into epigenetic process that control...[more]
IMB starts new International PhD Programme on “Dynamics of Gene Regulation, Epigenetics and DNA Damage Response“ in Mainz
Boehringer Ingelheim Foundation funds a new International PhD-Programme, in which 30 outstanding doctoral students from all over the world will work on innovative research projects / programme is coordinated by the Institute of...[more]
Holger Richly joins IMB to study stem cell differentiation and ageing
On 1st July Dr. Holger Richly joined the Institute of Molecular Biology (IMB) as the first of a second wave of new Group Leaders. His research aims at understanding how stem cells differentiate and why we grow old.[more]
IMB scientists find new regulatory mechanism
A recent study by IMB scientists uncovers a novel role for negative feedback of BMP4 in embryonic development.[more]
IMB officially opened 11 March 2011
Festive opening of the Institute of Molecular Biology at Johannes Gutenberg University Mainz[more]
Official topping-out ceremony
The topping-out ceremony (Richtfest) for IMB is celebrated by architects, constructors, politicians, administrators and scientists in Mainz (
IMB founding director announced
Prof. Dr. Christof Niehrs is the founding director of the new research centre, now officially named Institute of Molecular Biology ([more]
Construction of the new institute begins
Accelerated construction starts of a modern building for the newly established research centre of excellence in Mainz. The building work is financed by the federal state of Rheinland-Pfalz...[more]
New research centre for Mainz
Boehringer Ingelheim Foundation has announced its exceptional initiative to boost biomedical research in Mainz by funding a novel "centre of excellence for life sciences" with 100 million...[more]